| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 05/24/2000 | EP1002546A2 Use of esters or amides of hydroxylated carboxylic acid as solubilizers |
| 05/24/2000 | EP1002531A1 A water-miscible composition of non-steroidal antiinflammatory drugs |
| 05/24/2000 | EP1002513A1 Calcium phosphate cements containing polyalkene acids |
| 05/24/2000 | EP1002506A1 Radioactive stent |
| 05/24/2000 | EP1002065A1 Nanocrystalline formulations of human immunodeficiency virus (hiv) protease inhibitors using cellulosic surface stabilizers and methods of making such formulations |
| 05/24/2000 | EP1001996A1 Complex chemical compound, synthesis and various applications of said compound |
| 05/24/2000 | EP1001978A1 Angiotensin derivatives |
| 05/24/2000 | EP1001927A2 Novel polyamine analogues as therapeutic and diagnostic agents |
| 05/24/2000 | EP1001815A1 Vectors derived from antibodies for transferring substances into cells |
| 05/24/2000 | EP1001814A1 Controlled release microencapsulated ngf formulation |
| 05/24/2000 | EP1001813A1 Pharmaceutical formulations containing voriconazole |
| 05/24/2000 | EP1001812A1 Composition for the transdermal administration of steroid drugs |
| 05/24/2000 | EP1001799A1 Pharmaceutical composition containing peptichemio |
| 05/24/2000 | EP1001773A1 Oral solid pharmaceutical compositions containing nicorandil for a modulated release and the process for their preparation |
| 05/24/2000 | EP1001763A1 Aqueous compositions comprising ranitidine and lcmt sucrose |
| 05/24/2000 | EP1001759A2 Viral inhibition by long-chain alcohols, alkanes, fatty acids and amides |
| 05/24/2000 | EP1001757A1 Fast-acting analgesic |
| 05/24/2000 | EP1001751A1 Aqueous viscous compositions, whether clear or not, for making soft or hard capsules, and method for making films for such capsules |
| 05/24/2000 | EP1001750A1 Stable particulate complexes with neutral or negative globale charge of lamellar structure |
| 05/24/2000 | EP1001749A1 Proliposome powders for inhalation stabilised by tocopherol |
| 05/24/2000 | EP1001748A1 A process for the preparation of a granulate suitable to the preparation of rapidly disintegrable mouth-soluble tablets |
| 05/24/2000 | EP1001747A1 Compositions for nasal administration |
| 05/24/2000 | EP1001746A1 Fast-dissolving comestible units formed under high-speed/high-pressure conditions |
| 05/24/2000 | EP1001743A1 Implants for controlled release of pharmaceutically active principles and method for making same |
| 05/24/2000 | EP1001732A1 Shellac-containing cosmetic product |
| 05/24/2000 | EP0808332B1 Method for preparing collagen from cnidarians, and resulting cosmetic compositions |
| 05/24/2000 | EP0794788A4 Hepatic-directed compounds and reagents for preparation thereof |
| 05/24/2000 | EP0724452B1 Pharmaceutical composition containing cyclosporine a, a vitamine e derivative and an emulsifier |
| 05/24/2000 | EP0715638B1 Silicone grafted thermoplastic elastomeric copolymers and hair and skin care compositions containing the same |
| 05/24/2000 | CN1254293A Targeted therapeutic delivery of vitamin D compounds |
| 05/24/2000 | CN1254285A Use of zinc hyaluronate against peptic ulcer |
| 05/24/2000 | CN1254284A Activated protein C formulations |
| 05/24/2000 | CN1254278A Pharmaceutical injection solution containing taxol |
| 05/24/2000 | CN1253912A Production process of pharmaceutic water and its equipment |
| 05/24/2000 | CN1253781A CoA oral preparation for reducing blood fat and its preparation method |
| 05/24/2000 | CN1253771A Method for eliminating scabriculous and/or wrinkle and composite |
| 05/24/2000 | CN1052655C Human relaxin formulation |
| 05/23/2000 | US6066753 Mixtures of long-chain alkyl phosphates |
| 05/23/2000 | US6066718 Culturing host encoding dna capable of expressing antibody against immunoglobulin e, isolating, and conjugating with an enzyme, a fluorescent or chemiluminescent marker, a cytotoxic or cytostatic substance, radioactive label or others |
| 05/23/2000 | US6066620 Mixture with surfactant |
| 05/23/2000 | US6066619 Non-aqueous protic peptide formulations |
| 05/23/2000 | US6066616 Administering octreotide |
| 05/23/2000 | US6066345 Erythritol containing beverage imparting a cooling taste sensation |
| 05/23/2000 | US6066340 Process for the preparation of microspheres containing biologically active components |
| 05/23/2000 | US6066339 Controlled release coating of ammonia methacrylate copolymer |
| 05/23/2000 | US6066335 Method of producing effervescent tablets and effervescent tablet |
| 05/23/2000 | US6066334 Polyvinyl acetate, n-vinylpyrrolidone-containing polymer, water swellable agent, and water insoluble dusting agent; high speed release |
| 05/23/2000 | US6066319 Administering membrane attack complex (mac) transmembrane channel forming agent which is an antibody simultaneously therewith an effective amount of a therapeutic or diagnostic agent |
| 05/23/2000 | CA2253770A1 Pharmaceutical composition comprising bupropion hydrochloride |
| 05/23/2000 | CA2176712C Synthetic membrane vesicles with controlled release of encapsulated biologically active substances |
| 05/23/2000 | CA2048367C Solid oral forms of application containing ifosfamide as active substance |
| 05/23/2000 | CA2029596C Medicaments containing r-a-lipoic acid |
| 05/18/2000 | WO2000028554A1 Products and methods for brachytherapy |
| 05/18/2000 | WO2000028041A1 Delivery of superoxide dismutase to neuronal cells |
| 05/18/2000 | WO2000028019A2 Antisense oligomer |
| 05/18/2000 | WO2000028001A1 Modified exosomes and uses |
| 05/18/2000 | WO2000027999A2 Lymphoid tissue-specific cell production from hematopoietic progenitor cells in three-dimensional devices |
| 05/18/2000 | WO2000027874A2 Nucleic acids encoding transferrin receptor-like proteins and products related thereto |
| 05/18/2000 | WO2000027849A2 Therapeutic polymorphs of a gaba-a alpha-5 inverse agonist and pamoate formulations of the same |
| 05/18/2000 | WO2000027795A1 Transfection reagents |
| 05/18/2000 | WO2000027437A2 Polymer grafting by polysaccharide synthases |
| 05/18/2000 | WO2000027435A1 Antibody-serum protein hybrids |
| 05/18/2000 | WO2000027430A2 Composition consisting of influenza virus surface proteins and dispensing device |
| 05/18/2000 | WO2000027425A2 Pharmaceutical preparation containing a receptor-antagonist for treating blood-clotting disorders |
| 05/18/2000 | WO2000027419A1 Method for obtaining lyophilized pharmaceutical compositions of recombinant human erythropoietin stable at room temperature |
| 05/18/2000 | WO2000027402A1 Remedies for topical administration for iv type allergic diseases |
| 05/18/2000 | WO2000027398A1 Pharmaceutical moxifloxacin preparation |
| 05/18/2000 | WO2000027393A1 Powders containing tocotrienols, process for producing the same and tablets prepared by compression molding the same |
| 05/18/2000 | WO2000027392A1 Chromone enteric release formulation |
| 05/18/2000 | WO2000027390A1 Ionic silver complex |
| 05/18/2000 | WO2000027385A1 Dispersible compositions containing l-dopa ethyl ester |
| 05/18/2000 | WO2000027373A1 Dry powder pharmaceutical formulation |
| 05/18/2000 | WO2000027372A1 Pharmaceutical preparations for external use containing non-steroidal anti-inflammatory and analgesic agents |
| 05/18/2000 | WO2000027370A1 Controlled release formulation for water soluble drugs |
| 05/18/2000 | WO2000027369A1 Phospholipid-coated microcrystals for the sustained release of pharmacologically active compounds and methods of their manufacture and use |
| 05/18/2000 | WO2000027368A1 Particles coated with granulated crystalline ibuprofen |
| 05/18/2000 | WO2000027367A1 A capsule based drug delivery system |
| 05/18/2000 | WO2000027366A1 Pharmaceutical formulation comprising omeprazole |
| 05/18/2000 | WO2000027362A1 Method of producing vitamin powders |
| 05/18/2000 | WO2000027361A1 Stabilized nucleic acid compositions and methods of preparation and use thereof |
| 05/18/2000 | WO2000027360A1 Treatment set containing lungsurfactant compositions |
| 05/18/2000 | WO2000027359A1 An inhalation system |
| 05/18/2000 | WO2000027357A1 Improved fast disintegrating tablet |
| 05/18/2000 | WO2000027356A1 Self-foaming cleansing systems |
| 05/18/2000 | WO2000027207A1 Compositions of restricted cells capable of rapid growth which produce proliferation suppressive materials, and uses thereof |
| 05/18/2000 | WO2000009730A3 Cell type specific gene transfer using retroviral vectors containing antibody-envelope fusion proteins and wild-type envelope fusion proteins |
| 05/18/2000 | WO2000009097A3 Pharmaceutical composition with antitumor activity on the basis of carboplatin |
| 05/18/2000 | WO2000007979A3 Compounds and compositions for delivering active agents |
| 05/18/2000 | DE19853067A1 Radioaktiver Stent Radioactive stent |
| 05/18/2000 | DE19852826A1 Poly(alpha-1,4-D-Glucan) Poly (alpha-1,4-D-glucan) |
| 05/18/2000 | CA2351889A1 Lymphoid tissue-specific cell production from hematopoietic progenitor cells in three-dimensional devices |
| 05/18/2000 | CA2351063A1 A system for administering a bioactive agent by inhalation comprising a lipid mixture comprising phosphatidylcholine |
| 05/18/2000 | CA2350304A1 Dispersible compositions containing l-dopa ethyl ester |
| 05/18/2000 | CA2349947A1 Method of producing vitamin powders |
| 05/18/2000 | CA2349859A1 Stabilized nucleic acid compositions and methods of preparation and use thereof |
| 05/18/2000 | CA2349700A1 Therapeutic polymorphs of a gaba-a alpha-5 inverse agonist and pamoate formulations of the same |
| 05/18/2000 | CA2349679A1 Modified exosomes and uses |
| 05/18/2000 | CA2349644A1 Pharmaceutical preparation containing a receptor-antagonist for treating blood-clotting disorders |
| 05/18/2000 | CA2349496A1 Delivery of superoxide dismutase to neuronal cells |
| 05/18/2000 | CA2349445A1 Antisense oligomer |